Bridgeway Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Hold |
115,171
| – | – | ﹤0.01% | 1030 |
|
|
2025
Q1 | $127K | Sell |
115,171
-18,829
| -14% | -$20.7K | ﹤0.01% | 998 |
|
|
2024
Q4 | $230K | Sell |
134,000
-3,400
| -2% | -$5.85K | 0.01% | 975 |
|
|
2024
Q3 | $341K | Sell |
137,400
-11,000
| -7% | -$27.3K | 0.01% | 949 |
|
|
2024
Q2 | $359K | Hold |
148,400
| – | – | 0.01% | 931 |
|
|
2024
Q1 | $601K | Buy |
+148,400
| New | +$601K | 0.01% | 875 |
|
|
2023
Q4 | – | Sell |
-115,033
| Closed | -$477K | – | 1356 |
|
|
2023
Q3 | $477K | Sell |
115,033
-27,800
| -19% | -$115K | 0.01% | 888 |
|
|
2023
Q2 | $687K | Buy |
142,833
+25,000
| +21% | +$120K | 0.02% | 822 |
|
|
2023
Q1 | $478K | Buy |
117,833
+34,233
| +41% | +$139K | 0.01% | 900 |
|
|
2022
Q4 | $451K | Hold |
83,600
| – | – | 0.01% | 909 |
|
|
2022
Q3 | $839K | Buy |
83,600
+2,800
| +3% | +$28.1K | 0.02% | 771 |
|
|
2022
Q2 | $380K | Sell |
80,800
-49,600
| -38% | -$233K | 0.01% | 939 |
|
|
2022
Q1 | $510K | Buy |
+130,400
| New | +$510K | 0.01% | 926 |
|